These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 12761809)
1. Crystal forms of LY334370 HCl: isolation, solid-state characterization, and physicochemical properties. Reutzel-Edens SM; Kleemann RL; Lewellen PL; Borghese AL; Antoine LJ J Pharm Sci; 2003 Jun; 92(6):1196-205. PubMed ID: 12761809 [TBL] [Abstract][Full Text] [Related]
2. Crystal forms of the hydrogen oxalate salt of o-desmethylvenlafaxine. Dichiarante E; Curzi M; Giaffreda SL; Grepioni F; Maini L; Braga D J Pharm Pharmacol; 2015 Jun; 67(6):823-9. PubMed ID: 25644936 [TBL] [Abstract][Full Text] [Related]
3. Salt formation improved the properties of a candidate drug during early formulation development. Sigfridsson K; Ahlqvist M; Lindsjö M; Paulsson S Eur J Pharm Sci; 2018 Jul; 120():162-171. PubMed ID: 29730322 [TBL] [Abstract][Full Text] [Related]
5. Solid-state characterization and dissolution properties of Fluvastatin sodium salt hydrates. Borgmann SH; Bernardi LS; Rauber GS; Oliveira PR; Campos CE; Monti G; Cuffini SL; Cardoso SG Pharm Dev Technol; 2013; 18(2):525-34. PubMed ID: 23033850 [TBL] [Abstract][Full Text] [Related]
6. Crystal structure and physicochemical characterization of ambazone monohydrate, anhydrous, and acetate salt solvate. Muresan-Pop M; Braga D; Pop MM; Borodi G; Kacso I; Maini L J Pharm Sci; 2014 Nov; 103(11):3594-3601. PubMed ID: 25187325 [TBL] [Abstract][Full Text] [Related]
7. Use of CP/MAS solid-state NMR for the characterization of solvate molecules within estradiol crystal forms. Park JS; Kang HW; Park SJ; Kim CK Eur J Pharm Biopharm; 2005 Aug; 60(3):407-12. PubMed ID: 15996582 [TBL] [Abstract][Full Text] [Related]
8. Role of moisture on the physical stability of polymorphic olanzapine. Paisana MC; Wahl MA; Pinto JF Int J Pharm; 2016 Jul; 509(1-2):135-148. PubMed ID: 27234701 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the solubility and dissolution properties of several new rifampicin polymorphs, solvates, and hydrates. Henwood SQ; Liebenberg W; Tiedt LR; Lötter AP; de Villiers MM Drug Dev Ind Pharm; 2001 Nov; 27(10):1017-30. PubMed ID: 11794804 [TBL] [Abstract][Full Text] [Related]
10. Structural characterization, physicochemical properties, and thermal stability of three crystal forms of nifedipine. Caira MR; Robbertse Y; Bergh JJ; Song M; De Villiers MM J Pharm Sci; 2003 Dec; 92(12):2519-33. PubMed ID: 14603498 [TBL] [Abstract][Full Text] [Related]
11. Structural characterization, physicochemical properties, suspension stability, and adsorption properties of four solid forms of amitraz. de Villiers MM; van Eeden CM; Liebenberg W; Song M; Kolling WM; Caira MR J Agric Food Chem; 2004 Dec; 52(24):7362-9. PubMed ID: 15563220 [TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of stoichiometric and nonstoichiometric hydrate forms of paroxetine HCl: reversible changes in crystal dimensions as a function of water absorption. Pina MF; Pinto JF; Sousa JJ; Fábián L; Zhao M; Craig DQ Mol Pharm; 2012 Dec; 9(12):3515-25. PubMed ID: 23051151 [TBL] [Abstract][Full Text] [Related]
13. Preparation and solid state characterisation of chlorothiazide sodium intermolecular self-assembly suprastructure. Paluch KJ; Tajber L; McCabe T; O'Brien JE; Corrigan OI; Healy AM Eur J Pharm Sci; 2010 Dec; 41(5):603-11. PubMed ID: 20816757 [TBL] [Abstract][Full Text] [Related]
14. Physical characterization of anhydrous and hydrous forms of the hydrochloride salt of BVT.5182 a novel 5-HT(6) receptor antagonist. Hugerth A; Brisander M; Wrange U; Kritikos M; Norrlind B; Svensson M; Bisrat M; Ostelius J Drug Dev Ind Pharm; 2006 Feb; 32(2):185-96. PubMed ID: 16537199 [TBL] [Abstract][Full Text] [Related]
15. Two new polymorphs and one dihydrate of lenalidomide: solid-state characterization study. Jia L; Li Z; Gong J Pharm Dev Technol; 2019 Nov; 24(9):1175-1180. PubMed ID: 31282833 [No Abstract] [Full Text] [Related]
18. Rapid conversion of API hydrates to anhydrous forms in aqueous media. Petrova RI; Peresypkin A; Mortko CJ; McKeown AE; Lee J; Williams JM J Pharm Sci; 2009 Nov; 98(11):4111-8. PubMed ID: 19384923 [TBL] [Abstract][Full Text] [Related]
19. Screening and Characterization of Hydrate Forms of T-3256336, a Novel Inhibitor of Apoptosis (IAP) Protein Antagonist. Takeuchi S; Kojima T; Hashimoto K; Saito B; Sumi H; Ishikawa T; Ikeda Y Chem Pharm Bull (Tokyo); 2015; 63(11):858-65. PubMed ID: 26521850 [TBL] [Abstract][Full Text] [Related]